Development of a Drug Product workflow for Nitrosamine Risk Assessments

Duration - 49 Minutes

Price - INR-2000 / USD-70
Book Now   Enquire Now  

About the course

  • Development of a cross industry aligned approach to the nitrosamine risk assessment of drug products
  • GSK experiences of using this workflow to perform drug product risk assessments
  • Shared experiences relating to regulatory submissions

Speaker Profile

Dr. Mike Urquhart

Scientific Director
GSK Pharmaceuticals, UK

Website by: Xpoteck